The United States spends more on healthcare per capita than any other nation on earth — nearly twice as much as the average wealthy democracy. And yet, by virtually every health outcome measure — life expectancy, maternal mortality, infant mortality, chronic disease rates — America ranks in the bottom tier of developed nations.
This is not a new problem. It has been building for decades. But in 2024, with medical debt now the leading cause of personal bankruptcy in America, the system's failures have become impossible to ignore.
The Core Problem: A Market That Doesn't Work Like a Market
Healthcare is theoretically a market. But it is one where consumers frequently cannot compare prices, cannot meaningfully choose their provider in an emergency, often cannot understand what they are buying, and face life-or-death consequences for making the wrong choice. These are not conditions that produce efficient markets. They produce exploitation.
When you are having a heart attack, you do not shop around for the best price on a cardiologist. And the entire industry knows it.— Healthcare economist Dr. James Kwak
Who Is Actually Being Hurt
The conventional narrative suggests that the uninsured are the primary victims of American healthcare dysfunction. That is wrong — or at least incomplete. The underinsured — those with coverage that leaves them exposed to high deductibles and out-of-pocket costs — now number over 40 million Americans.
These are people who have insurance cards in their wallets but skip medications because of cost, delay care until problems become crises, and face financial devastation when serious illness strikes. They are overwhelmingly middle-class workers and their families.
100 million Americans carry medical debt. $220 billion in medical debt is held by Americans. The US spends $12,500 per person annually on healthcare — Canada spends $5,900 and covers everyone. 68% of all personal bankruptcies involve significant medical debt.
What Real Reform Would Require
There is no painless solution. Every serious healthcare reform proposal — Medicare for All, a public option, enhanced price negotiation — involves trade-offs and disruptions. What is not acceptable is continuing to pretend the current system is working because it is working for those who hold power within it.
Real reform would require price transparency that is actually transparent. It would require pharmaceutical pricing that reflects the research investment made by taxpayers, not just the monopoly pricing power of patent law. And it would require a political class willing to confront the lobbying power of an industry that spends $700 million a year on political influence.